Reproductive and Developmental Biology

The Korean Society of Animal Reproduction (한국동물번식학회)
권호 표지

Effect of an Anabolic Steroid, Nandrolone Decanoate, on Aquaporin 1 and 9 Gene Expression in the Rat Epididymis

  • Seo, Hee-Jung (Department of Biochemistry and Molecular Biology and Euiji University Medical Sciences Research Institute, School of Medicine, Euiji University) ;
  • Kang, Hyo-Jin (Department of Biochemistry and Molecular Biology and Euiji University Medical Sciences Research Institute, School of Medicine, Euiji University) ;
  • Choi, In-Ho (School of Biotechnology, Yeungnam University) ;
  • Cheon, Yong-Pil (School of Life Sciences and Chemistry, Institute of Basic Sciences, Sungshin Women's University) ;
  • Lee, Ki-Ho (Department of Biochemistry and Molecular Biology and Euiji University Medical Sciences Research Institute, School of Medicine, Euiji University)
  • Published : 2009.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The epididymis in the male reproductive tract is the site where spermatozoa produced from the testis become mature. The epididymis is divided into 4 different segments, initial segment and caput, corpus, and caudal epididymis, depending upon functional and morphological features. Aquaporins (Aqps) are water channel molecules, which are present in the epididymis and play a major role in removal of epididymal water, resulting in creation of microenvironment for sperm maturation and concentration of sperms. Nandrolone decanoate (ND) is a synthetic anabolic-androgenic steroid, which is used to treat clinical diseases and improve physical ability and appearance. Even though it is well determined that the ND causes the male infertility by affecting the testis, little is known the effect of the ND on the epididymis. The present study was focused to examine the effect of ND at different treatment doses and periods on expression of Aqp1 and Aqp9 genes in the epididymis of pubertal rats. Results showed that mRNA expression of Aqp1 and Aqp9 genes among the parts of the epididymis was differentially regulated by ND treatment doses. In addition, treatment periods of ND caused differential expression of Aqp1 and Aqp9 mRNAs among segments of the epididymis. Therefore, it is believed that male infertility induced by ND could be resulted not only from malfunction of the testis but also from aberrant gene expression of Aqp1 and Aqp9 in the epididymis.

Keywords

References

  1. Badran HH, Hermo LS (2002): Expression and regulation of aquaporins 1, 8, and 9 in the testis, efferent ducts, and epididymis of adult rats and during postnatal development. J Androl 23:358-373
  2. Basaria A, Wahlstrom, JT, Dobs AS (2001): Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 86:5108-5117 https://doi.org/10.1210/jc.86.11.5108
  3. Boyadjiev NP, Georgieva KN, Massaldjieva RI, Gueorguiev SI (2000): Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report. J Sports Med Phys Fitness 40:271-274
  4. Brown D, Verbabatz JM, Valenti G, Lui B, Sabolic I (1993): Localization of the CHIP28 water channel in reabsorptive segments of the rat male reproductive tract. Eur J Cell Biol 61:264-273
  5. Chrousos, GP (2006): The gonadal hormones and inhibitors. In: Katzung BG (ed.). Basic Clinical Pharmacology. McGraw-Hill Professional, pp 674-676
  6. Cornwall GA (2009): New insights into epididymal biology and function. Hum Reprod Update 15:213- 227 https://doi.org/10.1093/humupd/dmn055
  7. Cosentino MJ, Cokett AT (1986): Structure and function of the epididymis. Urol Res 14:229-240
  8. Da Silva N, Piétrement C, Brown D, Breton S (2006): Segmental and cellular expression of aquaporins in the male excurrent duct. Biochim Biophys Acta 1758: 1025-1033 https://doi.org/10.1016/j.bbamem.2006.06.026
  9. Dohle GR, Smit M, Weber RFA (2003): Androgens and male fertility. World J Urol 21:341-345 https://doi.org/10.1007/s00345-003-0365-9
  10. Domeniconi RF, Orsi AM, Justulin Jr LA, Beu CCL, Felisbino SL (2008): Immunolocalization of aquaporins 1, 2, and 7 in rete testis, efferent ducts, epdidiymis and vas deferens of adult dog. Cell Tissue Res 332:329-335 https://doi.org/10.1007/s00441-008-0592-x
  11. Fisher JS, Turner KJ, Fraser HM, Saunders PTK, Brown D, Sharpe RM (1998): Immunoexpression aquaporin-1 in the efferent ducts of the rat and marmoset monkey during development, its modulation by estrogens, and its possible role in fluid resorption. Endocrinology 139:3935-3945 https://doi.org/10.1210/en.139.9.3935
  12. Fortunato RA, Marassi MP, Chaves EA, Nascimento JH, Rosenthal D, Carvalho DP (2006): Chronic administration of anabolic androgenic steroid alters murine thyroid function. Med Sci Sports Exerc 38:256- 261 https://doi.org/10.1249/01.mss.0000183357.19743.51
  13. Grunfeld C, Kotler D, Dobs A, Glesby M, Bhasin S (2006): Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. J Acquir Immune Defic Syndr 41:304-314 https://doi.org/10.1097/01.qai.0000197546.56131.40
  14. Hermo L, Krzeczunowicz D, Ruz R (2004): Cell specificity of aquaporins 0, 3, and 10 expressed in the testis, efferent ducts, and epididymis of adult rats. J Androl 25:494-505
  15. Huang H-F, He R-H, Sun C-C, Meng Q-X, Ma Y-Y (2006): Function of aquaporins in female and male reproductive systems. Hum Reprod Update 12:785- 795 https://doi.org/10.1093/humupd/dml035
  16. Karbalay-Doust S, Noorafshan A (2006): Stereological study of the effects of nandrolone decanoate on the rat prostate. Micron 37:617-623 https://doi.org/10.1016/j.micron.2006.02.005
  17. Koeva YA, Georgieva KN, Atanassova PK, Delchev SD (2003): Effects of submaximal training and anabolic androgenic steroids administration on steroidogenic enzyme activity in rat Leydig cells. Folia Med (Plovdiv) 45:37-40
  18. Kruse E, Uehlein N, Kaldenhoff R (2006): The aquaporins. Genome Biol 7:206 https://doi.org/10.1186/gb-2006-7-2-206
  19. Lu DY, Li Y, Bi ZW, Yu HM, Li XJ (2008): Expression and immunohistochemical localization of aquaporin-1 in male reproductive organs of the mouse. Anat Histol Embryol 37:1-8 https://doi.org/10.1111/j.1439-0264.2007.00827.x
  20. Menon DK (2003): Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin. Fertil Steril 79:1659-1661 https://doi.org/10.1016/S0015-0282(03)00365-0
  21. Mulligan K, Schambelan M (2002): Anabolic treatment with GH, IGF-1, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol 85:151-159 https://doi.org/10.1016/S0167-5273(02)00247-4
  22. Nagata S, Kurosawa M, Mima K, Nambo Y, Fujii Y, Watanabe G, Taya K (1999): Effects of anabolic steroid (19-nortestosterone) on the secretion of testicular hormones in the stallion. J Reprod Fertil 115:373- 379 https://doi.org/10.1530/jrf.0.1150373
  23. Noorafshan A, Karbalay-Doust S, Ardekani FM (2005): High doses of nandrolone decanoate reduce volume of testis and length of seminiferous tubules in rats. APMIS 113:122-125 https://doi.org/10.1111/j.1600-0463.2005.apm1130205.x
  24. Oliveira CA, Carnes K, França LR, Hermo L, Hess RA (2005): Aquaporin-1 and -9 are differentially regulated by oestrogen in the efferent ductule epithelium and initial segment of the epididymis. Biol Cell 97: 385-395 https://doi.org/10.1042/BC20040078
  25. Pastor-Soler N, Isnard-Bagnis C, Herak-Kramberger C, Sabolic I, Van Hoek A, Brown D, Breton S (2002): Expression of aquaporin 9 in the adult rat epididymal epithelium is modulated by androgens. Biol Reprod 66:1716-1722 https://doi.org/10.1095/biolreprod66.6.1716
  26. Ranke MB, Bierich JR (1986): Treatment of growth hormone deficiency. Clinics Endocrinol Metabol 15: 495-510 https://doi.org/10.1016/S0300-595X(86)80008-1
  27. Shayu D, Kesava CC, Soundarajan R, Rao AJ (2005): Effects of ICI 182780 on estrogen receptor expression, fluid absorption and sperm motility in the epididymis of the bonnet monkey. Reprod Biol Endocrinol 3:10 https://doi.org/10.1186/1477-7827-3-10
  28. Sjoqvist F, Garle M, Rane A (2008): Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 371:1872-1882 https://doi.org/10.1016/S0140-6736(08)60801-6
  29. Takahashi M, Tatsugi Y, Kohno T (2004): Endocrinological and pathological effects of anabolic-androgenic steroid in male rats. Endocrine J 51:425-434 https://doi.org/10.1507/endocrj.51.425
  30. Van Der VJ (1965): On the mechanism of action of nandrolone phenylpropionate and nandrolone decanoate in rats. Acta Endocrinol (Copenh) 49:271-282
  31. Vieira RP, França RF, Damaceno-Rodrigues NR, Dolhnikoff M, Caldini EG, Carvalho CR, Ribeiro W (2008): Dose-dependent hepatic response to subchronic administration of nandrolone decanoate. Med Sci Sports Exerc 40:842-847 https://doi.org/10.1249/MSS.0b013e3181666f1c